Laurà Matilde, Milani Micaela, Morbin Michela, Moggio Maurizio, Ripolone Michela, Jann Stefano, Scaioli Vidmer, Taroni Franco, Pareyson Davide
UO Biochimica e Genetica, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.
J Neurol Neurosurg Psychiatry. 2007 Nov;78(11):1263-6. doi: 10.1136/jnnp.2006.112276.
Myelin protein zero (MPZ) is a major component of compact myelin in peripheral nerves where it plays an essential role in myelin formation and adhesion. MPZ gene mutations are usually responsible for demyelinating neuropathies, namely Charcot-Marie-Tooth (CMT) type 1B, Déjèrine-Sottas neuropathy and congenital hypomyelinating neuropathy. Less frequently, axonal CMT (CMT2) associated with MPZ mutations has been described. We report six patients (one sporadic case and five subjects from two apparently unrelated families) with a late onset, but rapidly progressive, axonal peripheral neuropathy. In all patients, molecular analysis demonstrated a novel heterozygous missense mutation (208C>T) in MPZ exon 2, causing the Pro70Ser substitution in the extracellular domain. The diagnosis of CMT2 associated with MPZ mutations should be considered in both sporadic and familial cases of late onset, progressive polyneuropathy. The mechanism whereby compact myelin protein mutations cause axonal neuropathy remains to be elucidated.
髓鞘蛋白零(MPZ)是周围神经紧密髓鞘的主要成分,在髓鞘形成和黏附中起重要作用。MPZ基因突变通常导致脱髓鞘性神经病,即1B型夏科-马里-图斯病(CMT)、德热里纳-索塔斯神经病和先天性髓鞘形成不足神经病。较少见的是,也有与MPZ突变相关的轴索性CMT(CMT2)的报道。我们报告了6例患者(1例散发病例和来自两个明显无亲缘关系家庭的5名受试者),他们患有迟发性但进展迅速的轴索性周围神经病。所有患者的分子分析均显示MPZ外显子2存在一种新的杂合错义突变(208C>T),导致细胞外结构域中的脯氨酸70被丝氨酸取代。对于迟发性、进行性多发性神经病的散发病例和家族性病例,均应考虑与MPZ突变相关的CMT2的诊断。紧密髓鞘蛋白突变导致轴索性神经病的机制仍有待阐明。